2-(1H-Indol-3-Yl)-Benzothiazole

Impregnation of analytical-grade cellulose filter paper with a 2-(1H-indol-3-yl)-benzothiazole solution in anhydrous tetrahydrofuran and ethyl acetate (4:1 v/v) at a functional loading of 0.03–0.07 mg/cm² yields a turn-off fluorescent test strip sensitive to Cu²⁺ in aqueous samples at pH 5.8–7.2. The manufacturing line operates with a slot-die coater configured at 3.5 m/min web speed through a 55 °C forced-air drying tunnel, after which the master roll is immediately slit and pouch-sealed under nitrogen with 20 g of silica gel desiccant per 100 strips to mitigate humidity-induced photobleaching. During scale-up runs on a Kroenert PAK 410 pilot coater, batch-to-batch fluorescence intensity variance remained within ±7 % when precursor solution viscosity was controlled to 4.2 ± 0.1 mPa·s and ambient relative humidity maintained below 38 %. The strips exhibit a Stern-Volmer quenching constant of 1.8 × 10⁴ M⁻¹ for Cu²⁺, with a detection limit calculated at 1.2 ppb per the 3σ/m criterion referenced in ASTM E2144-11. Quality control for export batches requires compliance with ISO 17381:2012 (selection and validation of rapid test methods for water quality) and documentation that the substrate has been produced under ISO 9001:2015 certified management. The end product is a ready-to-use test strip card sealed in aluminum trilaminate pouches for field detection of copper contaminants in electronics manufacturing wastewater.

Live-cell imaging workflows utilizing 2-(1H-indol-3-yl)-benzothiazole as a mitochondrial membrane-potential indicator require rigorous exclusion of serum-borne esterases that can cleave the benzothiazole ring in the presence of high-protein media; a pre-conjugated BSA-tracer prepared via EDAC/NHS coupling at a dye-to-protein ratio of 4:1 and diluted to a working concentration of 50–200 nM in phenol red-free DMEM achieves a signal-to-noise ratio exceeding 15:1 on a spinning-disc confocal system with 405 nm excitation and 60×/1.42 NA oil-immersion objective. The staining protocol mandates a 37 °C, 5% CO₂ incubation for 45 minutes, followed by three washes with pre-warmed Hank’s balanced salt solution; omission of the final wash step consistently generates diffuse cytoplasmic background that masks cristae-level resolution. Under continuous illumination at 1.5 mW/cm² for 120 seconds, photobleaching remains below 22%, a threshold verified across 12 independent HeLa cell preparations, yet exposure to ambient oxygen without the antioxidant ascorbate (added at 0.1 mM) accelerates signal decay by a factor of 1.8. Cytotoxicity assessed per ISO 10993-5:2009 indicates IC₅₀ > 100 μM after 24-hour exposure, placing the product in the low-toxicity category suitable for research-grade live-cell reagents. The final product format is a 1 mM anhydrous DMSO stock solution in amber ampules, packed under argon in secondary containment meeting IATA PI 650 for transport.

What Limits the External Quantum Efficiency of Indolylbenzothiazole-Based Emitters in Solution-Processed Phosphorescent OLEDs?

Emission in the deep-red region (λ_EL = 638 ± 4 nm) is obtained when 2-(1H-indol-3-yl)-benzothiazole is doped at 3.0 wt% into a mixed host of mCP and 30 wt% OXD-7, with the layer deposited inside a nitrogen-filled glovebox (H₂O < 0.1 ppm, O₂ < 0.5 ppm) via spin-coating from chlorobenzene at 1200 rpm and baked at 100 °C for 20 minutes to reduce pinhole density. The primary processing conflict arises from the compound’s sublimation onset temperature of 218 ± 3 °C at 10⁻⁶ mbar; attempts to thermally evaporate at source temperatures above 240 °C induce partial decomposition and a drift in deposition rate monitored on an INFICON quartz crystal microbalance, forcing the adoption of solution-processing as the sole viable route for fabrication. In a 10 cm² test pixel on an ITO/PEDOT:PSS anode, the external quantum efficiency plateaus at 4.8% at 3 mA/cm², after which triplet-triplet annihilation drives a roll-off to 3.1% at 50 mA/cm²; this behavior has been mapped in a Keithley 2400 source meter coupled with a calibrated integrating sphere per IEC 62341-5-1. The operational lifetime (LT₅₀) at 1000 cd/m² initial luminance is recorded at 820 hours under constant current driving, limited by electromer formation that is accelerated when the host matrix contains residual chloride above 5 ppm. Conformity to IEC 62341-1-1:2019 mandates testing for chromaticity shift (Δu’v’ < 0.01 after 500 hours) and compliance with RoHS 2011/65/EU for cadmium-free display components. Terminal goods are sealed glass-encapsulated OLED panels integrated into automotive dashboard indicators and wearable biometric monitors.

Fabrication of a distributed fiber-optic mercury sensor array involves covalent bonding of 2-(1H-indol-3-yl)-benzothiazole-5-carboxylic acid to amine-terminated silica fiber tips via EDC/HOBt carbodiimide chemistry at a loading of 0.8 ng/cm², followed by rigorous washing in acetonitrile to remove physisorbed species that otherwise contribute a background fluorescence drift of 2.3% per minute. Long-term drift tests conducted over 720 hours on a 16-channel array submerged in synthetic freshwater at 23 ± 1 °C show a sensitivity retention of 94% when the probe is overcoated with a sol-gel layer derived from tetraethoxysilane hydrolysed at pH 4.0; uncoated tips lose 41% of initial response within the same period. Under flow-injection analysis conditions with a peristaltic pump delivering sample at 0.8 mL/min and pH buffered to 6.8, the sensor achieves a Stern-Volmer constant of 2.3 × 10⁴ M⁻¹ for Hg²⁺, a 90% response time of 3.8 seconds, and a reversible signal recovery to 97% upon flushing with 10 mM EDTA. Cross-sensitivity to Ag⁺ and Pb²⁺ is suppressed to below 6% relative error by the incorporation of a 25 μm-thick Nafion™ cation-exchange barrier dip-coated prior to the sol-gel layer. Validation against ISO 5667-1:2020 sampling protocols and IEC 61757-1:2023 ensures the device meets the conformity requirements for in-line water quality monitoring in chlor-alkali plant effluent streams. The final product is a factory-calibrated probe assembly delivered with a factory-stored calibration curve embedded in the microcontroller of the interrogation unit.

Accelerated Weathering Crack Onset in Thin-Section PP Tapes Under 0.25 wt% Indolyl-Benzothiazole Stabilization

Melt-blending of the heterocyclic stabilizer with polypropylene homopolymer (MFI 3.2 g/10 min at 230 °C/2.16 kg) is performed on a co-rotating twin-screw extruder with L/D = 40 and medium shear screw profile, where the compound is metered via a loss-in-weight side feeder at zone 7 to limit total residence time above 220 °C to under 42 seconds. This configuration is dictated by a sharp process window: differential scanning calorimetry traces place the onset of thermal degradation at 277 °C under nitrogen, yet at screw speeds exceeding 350 rpm, friction-induced temperature spikes of 12–15 °C above the barrel setpoint are routinely recorded in zone 5 of a Leistritz ZSE 27 MAXX extruder, causing stabilizer loss of 8–11% as confirmed by UV-Vis assay of pellet extracts. The recommended addition range of 0.15–0.35 wt% is thus laterally fed rather than pre-blended, and a nitrogen blanket at 2.5 L/min is maintained over the feeder hopper to suppress oxidative yellowing during processing. Tapes drawn at 6:1 stretch ratio to a thickness of 45 μm and exposed in a Xenon-arc weatherometer per ISO 4892-3:2016 cycle A2 (with 0.55 W/m² at 340 nm) exhibit a 60% gloss retention after 2400 kJ/m² radiant exposure, versus 22% for an unstabilized control; however, when the same formulation is combined with a secondary hindered amine light stabilizer (HALS) at 0.1 wt%, a synergistic jump to 78% gloss retention is recorded, accompanied by a delay in crack onset from 1600 kJ/m² to 3400 kJ/m². Conversely, co-addition of amine-based process aids must be avoided because nucleophilic attack on the benzothiazole ring at melt temperatures opens a de-activation pathway that reduces the effective absorber concentration by 27% within the first 48 hours of accelerated aging as tracked by carbonyl index growth per ASTM D5576. The final woven fabric or woven tape product is deployed as FIBC bulk bags and outdoor furniture webbing, where REACH Annex XVII compliance and extractables below the 10 mg/dm² overall migration limit for food-contact applications (simulated per EN 1186-1) open routes into indirect food packaging.

When Indole-Benzothiazole Is Used as a Molecular Scaffold in the Synthesis of Dual EGFR/Src Kinase Inhibitors

The convergent synthetic route requires 2-(1H-indol-3-yl)-benzothiazole to be N-alkylated with 1-bromo-3-chloropropane in the presence of cesium carbonate (2.5 eq) in anhydrous dimethylformamide at 60 °C for 18 hours under argon, achieving a typical isolated yield of 71–76% after flash chromatography. The subsequent Suzuki-Miyaura coupling at the indole C-2 position with a pre-formed pinacol boronate ester demands a catalyst loading of Pd(PPh₃)₄ at 1.3 mol% and aqueous Na₂CO₃ (2 M) in dioxane at 85 °C for 12 hours, with strict exclusion of oxygen to prevent Pd black formation that contaminates the active pharmaceutical ingredient (API) beyond the permitted residual metal limit of 10 ppm palladium per ICH Q3D guidelines. Process analytical technology (PAT) implemented on a 100 L Hastelloy reactor tracks the disappearance of the benzothiazole-CH₂Cl intermediate via in-line Raman at 1550 cm⁻¹, enabling a crystallization trigger when the peak area falls below 0.5% of initial intensity. The recrystallized API batch must meet ≥ 99.8% HPLC purity with total related substances < 0.15% as per Ph. Eur. 2.2.29, and residual solvent limits for DMF < 880 ppm and dioxane < 380 ppm per ICH Q3C Class II thresholds. A major process stability issue emerges during storage: the unmilled API loses 0.3% potency per month at 25 °C/60% RH due to benzothiazole ring hydrolysis, necessitating double-blister packaging with aluminum foil and a desiccant canister to achieve 24-month shelf life as required by ICH Q1A(R2). The terminal dosage form is a hard gelatin capsule containing 50 mg or 150 mg of the micronized inhibitor, manufactured in an ISO 8 cleanroom under FDA 21 CFR Part 211 conditions and labelled for the treatment of advanced non-small-cell lung cancer as a third-line oral therapy.